Lingotek, Phase2 OpenPublic Take Open Government One Step

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lingotek, Phase2 OpenPublic Take Open Government One Step Further

LEHI, UT--(Marketwired - Jul 26, 2013) - Lingotek | The Translation Network and OpenPublic, have announced an integrated partnership to create a built-in translation solution for the open source distribution. With Lingotek's cloud-based translation management system built into OpenPublic, federal agencies, state and local governments, and nonprofit organizations will now have the opportunity to scale and broaden their global content systems within a secure, accessible OpenGov environment.

"OpenPublic is the premier CMS for government agencies to operate their website in a secure, trustworthy and scalable environment," said Robert Vandenberg, CEO of Lingotek. "Now with Lingotek - Inside OpenPublic, users can enjoy enhanced levels of multilingual functionality within that framework."

Built and maintained by Phase2, the web strategy, experience design, and technology agency for influential organizations across the public, private, and non-profit sectors, OpenPublic is the open source distribution developed to help build content management systems (CMS) and collaboration tools for government and public sector projects. Created with security and accessibility in mind, OpenPublic provides a flexible solution tailored for emerging internet and open government concerns, such as responsive web design, security compliance and customizable workflow administration.

The integration with Lingotek brings usability and accessibility to new levels by enabling users to translate content directly within their CMS workflow. Users can optimize budgets for the best translation workflow for their content, whether that be machine, community, or professional translation. Rather than a one-size-fits-all proposition, which often comes with steep costs, government users will be able to expedite and optimize translation, without ever leaving their CMS. Agencies will seamlessly be able to scale translation, meeting critical needs in many areas of government, from information to health care. 

"We are excited to be launching a streamlined and secure translation integration with Lingotek to the public sector and government agencies that have grown to rely on and trust OpenPublic," said Phase2 CEO Jeff Walpole. "With Lingotek's best-in-class services accessible to these groups, OpenPublic will offer real-time translation resources to enhance productivity and efficiency on a global scale."

The Lingotek and OpenPublic integration will launch in early August, and the app will be available on the OpenPublic app server for all existing OpenPublic sites.

Members of both the OpenPublic and Lingotek teams will be present at this year's CapitalCamp, a premiere Drupal camp for those in the Washington, DC area. This year's conference focuses on open government and Lingotek will have personnel and resources available at the event.

To learn more about Lingotek and Phase2 at CapitalCamp, go to: http://www.capitalcamp.org/content/lingotek ; http://www.capitalcamp.org/content/phase2

To learn more about Lingotek - Inside of OpenPublic, please visit: http://www.lingotek.com/phase2

To learn more about OpenPublic, please visit: http://openpublicapp.com/

ABOUT LINGOTEK Lingotek | The Translation Network helps your business access new markets and reach global customers. Lingotek - Inside content management system modules, along with its sophisticated cloud-based translation management system and extensive network of professional translation service providers, offer customers the ability to create and manage all of their multilingual content with ease. Today, global organizations, intelligence agencies and government entities use Lingotek, saving time and money. Lingotek was named by Gartner, Inc. as a 2012 Cool Vendor in Content Management. The company is based in Lehi, Utah and is funded by Signal Peak Ventures and In-Q-Tel .

About OpenPublic OpenPublic ( www.openpublicapp.com ) is an open source distribution developed to help build content management systems (CMS) and collaboration tools tailored for the needs of government, open government, and public sector initiatives. Built with security and accessibility in mind, OpenPublic provides an enterprise-grade web experience that gives federal agencies, state and local governments, and nonprofit organizations a jump-start on creating websites that serve their constituencies. Phase2 is the builder and maintainer of OpenPublic and we offer packaged support for small sites as well as custom enterprise platform development services.

About Phase2 Phase2 ( www.phase2technology.com ) is a web strategy, experience design, and technology implementation for influential organizations across the public, private, and non-profit sectors. With offices in Washington, DC & New York, and teams across the county, Phase2 is committed to improving the way the world's most influential organizations achieve their goals through open source technology. Founded in 2001, Phase2 has worked with clients in targeted verticals including education, government, publishing and media, healthcare, and non-profits. Focusing on web strategy, design, and development, the Phase2 team has extensive knowledge in the areas of content management, open data integration, community applications, APIs, and custom application development.

MEDIA CONTACT Calvin Scharffs Lingotek 801-331-7777 ext 115 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 125

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 221

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 167

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 44

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

We Energies Recognized for Exceptional Reliability Standards

Updated Category News Views 172

We Energies Celebrated for Excellence in Reliability MILWAUKEE / We Energies has recently been honored with the esteemed 2025 ReliabilityOne® Award, recognizing its superior performance in delivering reliable electric service. This accolade is a testament to the dedication and expertise of its workforce, as well as the strategic investments the company has made to...

Continue Reading
MicroStrategy Options Activity: Insights and Market Trends

Updated Category News Views 59

What Recent Options Activity Says About MicroStrategy Options flow often hints at how the crowd feels before price moves show it. Lately, the tone around MicroStrategy (MSTR) has leaned bearish, a point worth noting if you’re weighing your own trades. The signal isn’t subtle: activity has picked up sharply, and that surge alone can draw in traders who watch sentiment...

Continue Reading
Viactiv Expands Wellness Line with New Chews and Powder

Updated Category News Views 16

Viactiv Expands Beyond Calcium Forget just bone health; Viactiv is stepping up its game. They've gone beyond their trusty calcium chews with something new that targets women’s wellness in a broader sense. Meet the newcomers: Viactiv® CoQ10 CARDIO Complete Soft Chews and Viactiv® Magnesium Glycinate Powder. Ain't that a mouthful? But seriously, these are designed for...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 107

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Insights into Tryg A/S Q4 2024 Performance and Expectations

Updated Category News Views 260

Overview of Tryg A/S Q4 2024 Newsletter As the end of the year approaches, Tryg A/S is gearing up for a busy period of financial disclosures and investor engagement. In the week commencing mid-December, Tryg will conduct several pre-close analyst calls and meetings. This initiative is designed to prepare stakeholders ahead of the crucial Q4 2024 results release, which is...

Continue Reading